anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

207,241-207,300 of 319,975

filter-aware
01
Slide 1
Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slidesAeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank Beat · Situation & Context1 hit
02
Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slidesAeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank Beat · Situation & Context1 hit
03
The slide details a corporate acquisition and concurrent private placement financing.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank Beat · Situation & Context1 hit
04
Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slidesAeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank Beat · Situation & Context1 hit
05
The slide uses a Gantt-style visualization to show the development status of various drug candidates.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank Beat · Problem & Complication1 hit
06
Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slidesAeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank Beat · Problem & Complication1 hit
07
The chart uses a conceptual scatter plot to contrast current SOC with a future target state, emphasizing the need for higher efficacy and better convenience.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank Beat · Problem & Complication1 hit
08
The slide uses a numbered list format to present the company's core strategic pillars.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank Beat · Problem & Complication1 hit
09
The chart illustrates the correlation between Cyno and Human half-life, showing YTE mAbs (Spyre's approach) outperforming WT mAbs.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank Beat · Solution & ApproachLoop · Golden Circle1 hit
10
The slide uses a visual metaphor of two antibodies merging into a single complex to represent combination therapy.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank Beat · Solution & ApproachLoop · Golden Circle1 hit
11
The Venn diagram shows the intersection of genetic targets (TL1A, IL-23, a4b7). The bar chart compares 'All-comers' vs 'CDx+' (companion diagnostic positive) patient groups for two drugs (PRA023 and RVT-3101).Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank Beat · Solution & ApproachLoop · Golden Circle1 hit
12
The slide uses a Gantt-style visualization to show the progression of various drug programs (SPY001-SPY230).Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank Beat · Solution & ApproachLoop · Golden Circle1 hit
13
The slide uses a matrix-like layout to map strategy (mAbs vs combinations) to specific programs and their development status (Discovery, IND-Enabling, Clinical).Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
14
Includes a testimonial quote from a US KOL.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
15
The chart uses a vertical axis to categorize drugs by mechanism of action (α4β7, IL-23s, TNFαs, S1P1s, JAKs) and a horizontal axis for efficacy (Pbo-adjusted clinical remission %).Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
16
The table uses checkmarks for positive attributes and arrows for 'potential upside' to differentiate SPY001's superior profile.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
17
The slide uses a Y-shaped antibody diagram to annotate specific functional improvements.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
18
The slide uses a structural model of the protein complex and two dose-response curves to demonstrate efficacy and selectivity.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
01
Slide 1
a.k.a. Brands | Investor Presentation Deck | 13 slidesa.k.a. Brands | Investor Presentation Deck | 13 slides · a.k.a. Brands
Pitch deck Investor relations 1 hit
02
a.k.a. Brands | Investor Presentation Deck | 13 slidesa.k.a. Brands | Investor Presentation Deck | 13 slides · a.k.a. Brands
Pitch deck Investor relations Beat · ProblemLoop · Why Now1 hit
03
The slide features logos and imagery for brands like Culture Kings, Petal & Pup, MNML, and Princess Polly.a.k.a. Brands | Investor Presentation Deck | 13 slides · a.k.a. Brands
Pitch deck Investor relations Beat · ProblemLoop · Why Now1 hit
04
The slide uses a contrast-pairs framework to differentiate the company from traditional retail incumbents.a.k.a. Brands | Investor Presentation Deck | 13 slides · a.k.a. Brands
Pitch deck Investor relations Beat · ProblemLoop · Why Now1 hit
05
The slide uses a table-like structure to map strategic pillars to operational outcomes.a.k.a. Brands | Investor Presentation Deck | 13 slides · a.k.a. Brands
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit
06
The slide uses a numbered list format to organize four distinct financial pillars.a.k.a. Brands | Investor Presentation Deck | 13 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Solution1 hit
07
Includes a source note for the 'Top 10 fashion website' claim.a.k.a. Brands | Investor Presentation Deck | 13 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Market Size1 hit
08
a.k.a. Brands | Investor Presentation Deck | 13 slidesa.k.a. Brands | Investor Presentation Deck | 13 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Market Size1 hit
09
The slide uses a mix of brand identity, business metrics, and lifestyle imagery to define the company's market position.a.k.a. Brands | Investor Presentation Deck | 13 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Market Size1 hit
10
The slide uses a brand-focused layout with descriptive text on the left and lifestyle imagery on the right and bottom.a.k.a. Brands | Investor Presentation Deck | 13 slides · a.k.a. Brands
Pitch deck Investor relations Beat · Market Size1 hit
11
The slide uses a split-layout with a lifestyle image on the left and strategic bullet points on the right.a.k.a. Brands | Investor Presentation Deck | 13 slides · a.k.a. Brands
Pitch deck Investor relations Beat · TeamLoop · Quick Win Big Bet1 hit
12
The slide serves as a portfolio or proof-of-concept gallery demonstrating the company's capability in executing brand activations.a.k.a. Brands | Investor Presentation Deck | 13 slides · a.k.a. Brands
Pitch deck Investor relations Beat · TeamLoop · Quick Win Big Bet1 hit
13
a.k.a. Brands | Investor Presentation Deck | 13 slidesa.k.a. Brands | Investor Presentation Deck | 13 slides · a.k.a. Brands
Pitch deck Investor relations Beat · TeamLoop · Quick Win Big Bet1 hit
08
The slide includes a footnote defining Marketplace GOV.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · FinancialsLoop · So What Cascade1 hit
09
Includes margin percentages overlaid on bar charts.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · FinancialsLoop · So What Cascade1 hit
10
Includes a non-GAAP disclaimer footnote.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · Financials1 hit
11
The slide uses a hub-and-spoke diagram to center 'Strategic Flexibility' as the outcome of four financial pillars.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · Financials1 hit
12
Vivid Seats | Results Presentation Deck | 20 slidesVivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations Beat · Solution1 hit
13
Vivid Seats | Results Presentation Deck | 20 slidesVivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations 1 hit
14
Vivid Seats | Results Presentation Deck | 20 slidesVivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations 1 hit
15
Vivid Seats | Results Presentation Deck | 20 slidesVivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations 1 hit
16
The slide explains the dual-class structure and how it relates to financial reporting and economic interest.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations 1 hit
17
Data presented in thousands, except for per-share amounts.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations 1 hit
18
The chart includes a trend line showing a 3-4% CAGR over the period.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations 1 hit
19
The table includes footnotes (1-8) for specific line items.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations 1 hit
20
This slide serves as a technical appendix for financial disclosures, specifically explaining adjustments and corporate history.Vivid Seats | Results Presentation Deck | 20 slides · Vivid Seats
Conference presentation Investor relations 1 hit
01
Slide 1
The slide displays seven distinct brand identities under the Yatsen umbrella.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations 1 hit
02
Yatsen | Results Presentation Deck | 16 slidesYatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations 1 hit
03
Yatsen | Results Presentation Deck | 16 slidesYatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Attention1 hit
04
Yatsen | Results Presentation Deck | 16 slidesYatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations 1 hit
05
Data source: China National Bureau of Statistics (CNBS).Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
06
The slide highlights improvements in skincare revenue, gross margin, S&M expense efficiency, and a shift to GAAP profitability.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
07
Yatsen | Results Presentation Deck | 16 slidesYatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
08
Includes revenue from DR.WU (mainland China), Galénic, Eve Lom, Abby's Choice, and others.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Loop · So What Cascade1 hit
09
The slide highlights a 59% YoY growth in combined net revenues for the three brands.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Loop · So What Cascade1 hit
10
The chart highlights a strategic reduction in offline retail footprint throughout 2022.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations 1 hit
11
Yatsen | Results Presentation Deck | 16 slidesYatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Visualization1 hit
12
Data shows a decline in revenue but an improvement in gross margin.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Visualization1 hit
13
The slide explains the drivers behind the reduction in G&A and S&M expenses, specifically citing share-based compensation reversals and store closures.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Visualization1 hit
14
Includes a footnote explaining the non-GAAP definition and methodology.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Visualization1 hit
15
The chart displays quarterly operating cashflow as bars and the total cash balance as oval-enclosed numbers above the bars.Yatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations Beat · Visualization1 hit
16
Yatsen | Results Presentation Deck | 16 slidesYatsen | Results Presentation Deck | 16 slides · Yatsen Holding Limited
Conference presentation Investor relations 1 hit